NCT02223923 2025-08-01
Patriot
Royal Marsden NHS Foundation Trust
Phase 1 Unknown
Clinical Trials
193 trialsNCT06322095 2024-10-01
A Study of GH21 Combined With Previous Target Therapy or Immunotherapy in Patients With Advanced Solid Tumors
Suzhou Genhouse Bio Co., Ltd.
Phase 2 Unknown
NCT06136065 2024-06-04
FAPI
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 2 Unknown
NCT06326242 2024-03-22
What Unmet Need for the Patients?A Focus on the Social Determinants of Health in Phase 1 Clinical Trials
European Institute of Oncology
Unknown
NCT06281860 2024-02-28
PITHAC
Centre Hospitalier Universitaire Vaudois
Phase 1 Unknown
NCT06262581 2024-02-16
Neoadjuvant Tisleizumab(BGB-A317) for dMMR/MSI-H Non-late Stage CRC Patients Before Surgery
Sun Yat-sen University
Phase 2 Unknown
NCT06240767 2024-02-05
Clinical Study on the Treatment of Advanced Recurrent Tumors With Anticancer Mouse Characteristic Human Neutrophils
Wuxi People's Hospital
Phase 1 Unknown
NCT05291182 2024-02-02
A Phase I Study of SY-4835 in Patients With Advanced Solid Tumors
Shouyao Holdings (Beijing) Co. LTD
Phase 1 Unknown
NCT04823741 2024-02-01
SCITH-MESO
Hospices Civils de Lyon
Unknown
NCT05576961 2024-01-23
Safety and Efficacy of RX-af01 Combined With PD-1 Antibody
Sun Yat-sen University
Phase 1/2 Unknown
NCT05955157 2024-01-10
Combined S-1 With DC+CIK As Maintenance Therapy For Advanced Pancreatic Ductal Adenocarcinoma
University of Malaya
Phase 2/3 Unknown
NCT04983745 2023-12-21
DIDO
West Cancer Center
Phase 2 Unknown
NCT06171971 2023-12-15
CS-PEDIA
University Hospital, Strasbourg, France
Unknown
NCT05322512 2023-11-29
Nectin-4 Targeting ADC Probe for PET Imaging in Solid Tumors
Peking University Cancer Hospital & Institute
Phase NA Unknown
NCT04564521 2023-11-22
Nitroglycerin for Intra-arterial Chemotherapy in Pediatric Retinoblastoma.
Seoul National University Hospital
Phase NA Unknown
NCT06004713 2023-10-25
Registry Study in MSI/dMMR Solid Tumors
Peking University Cancer Hospital & Institute
Unknown
NCT04670445 2023-10-23
UPLIFT
Massachusetts General Hospital
Phase NA Unknown
NCT06082557 2023-10-13
A Study to Observe and Evaluate the Safety and Efficacy of T60c Injection for Treatment of Advanced Solid Tumor Patients
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1/2 Unknown
NCT06082570 2023-10-13
A Study to Observe and Evaluate the Safety and Efficacy of c610 Injection for Treatment of Advanced Solid Tumor Patients
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1/2 Unknown
NCT06030869 2023-09-11
MyCustom:Prospective Master Protocol Trial on Precision Medicine Treatment for Refractory Solid Tumors
Tianjin Medical University Second Hospital
Unknown
NCT06006793 2023-09-01
A Study of SY-5933 in Patients With Advanced Solid Tumors Harboring the KRAS p.G12C Mutation
Shouyao Holdings (Beijing) Co. LTD
Phase 1 Unknown
NCT06022276 2023-09-01
Nimotuzumab for EGFR-amplified Advanced Pan Solid Tumors
Tianjin Medical University Second Hospital
Phase NA Unknown
NCT06022289 2023-09-01
Pemigatinib for FGF/FGFR Alterations Advanced Pan Solid Tumors
Tianjin Medical University Second Hospital
Phase 2 Unknown
NCT04280341 2023-08-25
JS001 in Combination With RC48-ADC in Treatment of HER2-Positive Advanced Malignant Solid Tumors
Peking University
Phase 1 Unknown
NCT06009835 2023-08-24
DOTr/DOTa Algorithm Guidance for Refractory Solid Tumors
Tianjin Medical University Second Hospital
Unknown
NCT06010277 2023-08-24
FLEX
Amphia Hospital
Phase 4 Unknown
NCT05976906 2023-08-04
Universal Dual-target NKG2D-NKp44 CAR-T Cells in Advanced Solid Tumors
Zhejiang University
Phase 1 Unknown
NCT05972460 2023-08-02
IMM2510, a PD-L1 and VEGF Bispecific Fusion Protein, in Patients With Advanced Solid Tumors
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Phase 1 Unknown
NCT05942378 2023-07-12
A Study of HRXG-K-1939 and Adebrelimab in Patients With Advanced Solid Tumors
Fudan University
Phase 1 Unknown
NCT05940181 2023-07-11
A Safety and Efficacy Study of XH001 Combined With Sintilimab Injection in Advanced Solid Tumors
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Phase NA Unknown
NCT03810339 2023-06-27
Toripalimab as Monotherapy in Participants With POLE or POLD-1 Mutated and Non-MSI-H Advanced Solid Tumors
Sun Yat-sen University
Phase 2 Unknown
NCT05910112 2023-06-18
PROSPECT
University of Oxford
Unknown
NCT05747339 2023-06-13
A Clinical Study on the Efficacy and Mechanism of Tumor Treatment Vaccine (TTV) for Recurrent and Refractory Advanced Solid Tumors
Wuxi People's Hospital
Phase NA Unknown
NCT04631731 2023-06-01
ICEMELT
Western Sydney Local Health District
Phase 1/2 Unknown
NCT05359354 2023-05-16
Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Solid Tumors
Peking Union Medical College Hospital
Phase NA Unknown
NCT04940637 2023-05-12
UNITO-001
University of Turin, Italy
Phase 2 Unknown
NCT05848999 2023-05-12
UCLM802 (Anti-Mesothelin CAR-T) Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors
Zhejiang University
Phase 1 Unknown
NCT05498519 2023-05-11
A First-in-Human, Phase 1 Study of SY-4798 in Patients With Advanced Solid Tumor
Shouyao Holdings (Beijing) Co. LTD
Phase 1 Unknown
NCT05837299 2023-05-01
A Study of IMC008 for Advanced Solid Tumors
Changhai Hospital
Phase 1 Unknown
NCT05833984 2023-04-27
Safety and Efficacy of IMM01 Plus Tislelizumab in Patients With Advanced Solid Tumors and Lymphomas
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Phase 1/2 Unknown
NCT04700514 2023-04-24
Effect of Anesthetic Drugs on Neurocognitive Function in Children With Retinoblastoma Requiring Multiple Anesthetic Exposure - Preliminary Study
Seoul National University Hospital
Phase NA Unknown
NCT05815290 2023-04-18
Cadonilimab in Locally Advanced MSI-H/dMMR Colorectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Unknown
NCT04571892 2023-04-12
A Clinical Study to Observe the Safety and Efficacy of ScTIL210 in the Treatment of Malignant Solid Tumors
Shanghai East Hospital
Phase 1/2 Unknown
NCT05805956 2023-04-10
IMM2902 in Patients With Advanced Solid Tumors Expressing HER2
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Phase 1/2 Unknown
NCT04542863 2023-03-29
The Molecular Imaging Research of F-18 Labeled DX600 PET Probe
Peking University Cancer Hospital & Institute
Phase NA Unknown
NCT04214717 2023-03-28
DC-CIK
Yantai Yuhuangding Hospital
Phase NA Unknown
NCT04214730 2023-03-28
NK
Yantai Yuhuangding Hospital
Phase NA Unknown
NCT05775666 2023-03-20
UCLM802 (Anti-Mesothelin CAR-T) Cell Injection in Patients With Mesothelin-positive Advanced Malignant Solid Tumors
Peking University
Phase 1 Unknown
NCT03654833 2023-03-14
MiST
University of Leicester
Phase 2 Unknown
NCT05429866 2023-03-08
Immunological Variables Associated to ICI Toxicity in Cancer Patients
Jules Bordet Institute
Phase 2 Unknown